La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references indexed by treatment

Number of relevant bibliographic references: 244.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000008 (2017) Christopher H. Gibbons [États-Unis] ; Peter Schmidt [États-Unis] ; Italo Biaggioni [États-Unis] ; Camille Frazier-Mills [États-Unis] ; Roy Freeman [États-Unis] ; Stuart Isaacson [États-Unis] ; Beverly Karabin [États-Unis] ; Louis Kuritzky [États-Unis] ; Mark Lew [États-Unis] ; Phillip Low [États-Unis] ; Ali Mehdirad [États-Unis] ; Satish R. Raj [Canada] ; Steven Vernino [États-Unis] ; Horacio Kaufmann [États-Unis]The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
000052 (2017) Elizabeth J. Slow [Canada] ; Anthony E. Lang [Canada]Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment.
000096 (2017) Olivier Girard-Joyal [Canada] ; Nafissa Ismail [Canada]Effect of LPS treatment on tyrosine hydroxylase expression and Parkinson-like behaviors.
000110 (2017) Melanie Tremblay [Canada] ; Mason M. Silveira [Canada] ; Sukhbir Kaur [Canada] ; Jay G. Hosking [Canada] ; Wendy K. Adams [Canada] ; Christelle Baunez [France] ; Catharine A. Winstanley [Canada]Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns.
000120 (2017) Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada]Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
000131 (2017) Zahra Goodarzi [Canada] ; Zahinoor Ismail [Canada]A practical approach to detection and treatment of depression in Parkinson disease and dementia.
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000154 (2016) Jerry M. Cuttler [Canada] ; Eugene R. Moore [États-Unis] ; Victor D. Hosfeld [États-Unis] ; David L. Nadolski [États-Unis]Treatment of Alzheimer Disease With CT Scans
000173 (2016) B J Mcmahon [États-Unis] ; M G Bruce [États-Unis] ; A. Koch [Danemark] ; K J Goodman [Canada] ; V. Tsukanov [Russie] ; G. Mulvad ; M L Borresen [Danemark] ; F. Sacco [États-Unis] ; D. Barrett [États-Unis] ; S. Westby [États-Unis] ; A J Parkinson [États-Unis]The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary.
000290 (2016) Nathan C. Rowland [États-Unis] ; Suneil K. Kalia [Canada] ; Lorraine V. Kalia [Canada] ; Paul S. Larson [États-Unis] ; Daniel A. Lim [États-Unis] ; Krystof S. Bankiewicz [États-Unis]Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson’s disease
000333 (2016) Cicely Kerr [Royaume-Uni] ; Emily J. Lloyd [Royaume-Uni] ; Charlotte E. Kosmas [Royaume-Uni] ; Helen T. Smith [Royaume-Uni] ; James A. Cooper [Royaume-Uni] ; Karissa Johnston [Canada] ; Emma Mcintosh [Royaume-Uni] ; Andrew J. Lloyd [Royaume-Uni]Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.
000337 (2016) Laura C. Coates [Royaume-Uni] ; Arthur Kavanaugh ; Philip J. Mease [États-Unis] ; Enrique R. Soriano [Argentine] ; Maria Laura Acosta-Felquer [Argentine] ; April W. Armstrong [États-Unis] ; Wilson Bautista-Molano [Colombie] ; Wolf-Henning Boehncke [Suisse] ; Willemina Campbell [Canada] ; Alberto Cauli [Italie] ; Luis R. Espinoza ; Oliver Fitzgerald [Irlande (pays)] ; Dafna D. Gladman [Canada] ; Alice Gottlieb [États-Unis] ; Philip S. Helliwell [Royaume-Uni] ; M Elaine Husni [États-Unis] ; Thorvardur J. Love [Islande] ; Ennio Lubrano [Italie] ; Neil Mchugh [Royaume-Uni] ; Peter Nash [Australie] ; Alexis Ogdie [États-Unis] ; Ana-Maria Orbai [États-Unis] ; Andrew Parkinson [Royaume-Uni] ; Denis O'Sullivan [Irlande (pays)] ; Cheryl F. Rosen [Canada] ; Sergio Schwartzman [États-Unis] ; Evan L. Siegel [États-Unis] ; Sergio Toloza [Argentine] ; William Tuong ; Christopher T. Ritchlin [États-Unis]Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
000351 (2016) Li-Li Zhang ; S. Duff Canning [Canada] ; Xiao-Ping WangFreezing of Gait in Parkinsonism and its Potential Drug Treatment
000372 (2016) Laleh Golestanirad [États-Unis] ; Behzad Elahi ; Simon J. Graham [Canada] ; Sunit Das [Canada] ; Lawrence L. Wald [États-Unis]Efficacy and Safety of Pedunculopontine Nuclei (PPN) Deep Brain Stimulation in the Treatment of Gait Disorders: A Meta-Analysis of Clinical Studies.
000395 (2016) Abdul Qayyum Rana ; Mohamad Saleh ; Muhammad Saad Yousuf ; Wasim Mansoor ; Syed Hussaini ; Maniza Rahman ; Zohair IqbalDOPA-sparing strategy in the treatment of young onset Parkinson's disease
000450 (2016) Maribel Márquez-Cruz [Mexique] ; Juan Pablo Díaz-Martínez [Canada] ; Herman Soto-Molina [Mexique] ; Adib Jorge De Saráchaga [Mexique] ; Amin Cervantes-Arriaga [Mexique] ; Rodrigo Llorens-Arenas [Mexique] ; Mayela Rodríguez-Violante [Mexique]A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America.
000485 (2015) Zhen Ni ; Robert ChenTranscranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases
000518 (2015) Silvia Rios Romenets [Canada] ; Julius Anang [Canada] ; Seyed-Mohammad Fereshtehnejad [Suède] ; Amelie Pelletier [Canada] ; Ronald Postuma [Canada]Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study.
000552 (2015) Anosha Zanjani [Canada] ; Konstantine K. Zakzanis [Canada] ; Zafiris J. Daskalakis [Canada] ; Robert Chen [Canada]Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.
000580 (2015) Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada]Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.
000582 (2015) Kaviraja Udupa [Canada] ; Susan H. Fox [Canada]Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "treatment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    treatment
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022